NCLEX Review Guide: Prokinetic Agents

Definition and Mechanism of Action

• Prokinetic agents are medications that enhance gastrointestinal motility by stimulating muscle contractions throughout the digestive tract. These drugs work by blocking dopamine receptors or enhancing acetylcholine activity, which increases the strength and coordination of GI muscle contractions.
• Primary mechanism involves dopamine D2 receptor antagonism in the chemoreceptor trigger zone and GI tract, leading to increased gastric emptying and reduced nausea/vomiting.

Primary Agents

• Metoclopramide (Reglan) is the most commonly used prokinetic agent that blocks dopamine receptors and enhances acetylcholine release. It's used for gastroparesis, GERD, and postoperative nausea/vomiting with typical dosing of 10-15mg PO/IV every 6 hours.
• Domperidone works similarly to metoclopramide but doesn't cross the blood-brain barrier, reducing CNS side effects. It's primarily used for gastroparesis and functional dyspepsia but has limited availability in the US.

Primary Uses

• Gastroparesis (delayed gastric emptying) is the primary indication, especially in diabetic patients where prokinetic agents help move food from stomach to small intestine. Treatment typically continues for 2-8 weeks depending on symptom resolution.
• Gastroesophageal reflux disease (GERD) management by increasing lower esophageal sphincter pressure and promoting gastric emptying to reduce acid reflux episodes.
• Prevention and treatment of postoperative nausea and vomiting (PONV) by blocking dopamine receptors in the chemoreceptor trigger zone.

Critical Monitoring Points

• Extrapyramidal symptoms (EPS) including tardive dyskinesia, dystonia, and parkinsonism can occur, especially with prolonged use >12 weeks or high doses. Monitor for involuntary muscle movements, tremors, and restlessness.
• Contraindications include GI obstruction, perforation, or hemorrhage as increased motility could worsen these conditions and cause serious complications.
• Common side effects include drowsiness, fatigue, diarrhea, and restlessness which typically resolve with continued use or dose adjustment.

Proper Administration

1. Administer 30 minutes before meals and at bedtime for optimal effectiveness in promoting gastric emptying
2. Start with lowest effective dose and titrate based on patient response to minimize side effects
3. Limit duration to 12 weeks maximum to prevent tardive dyskinesia development
4. Monitor for therapeutic response within 2-4 weeks of initiation